Log in
Enquire now
‌

US Patent 7217815 2-beta -modified-6-substituted adenosine analogs and their use as antiviral agents

Patent 7217815 was granted and assigned to Valeant Pharmaceuticals on May, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Valeant Pharmaceuticals
Valeant Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7217815
Patent Inventor Names
Haoyun An0
Zhi Hong0
Yili Ding0
Stephanie Z. Shaw0
Date of Patent
May 15, 2007
Patent Application Number
10530627
Date Filed
October 23, 2002
Patent Primary Examiner
‌
Shaojia Anna Jiang
Patent abstract

Various 2′-beta-methyl-6-substituted adenosine analogs (including 2,6-disubstituted adenosine, 8-aza-6-substituted adenosine, and 2-aza-6-substituted adenosine) are prepared by conventional and combinatorial library approaches. Contemplated compounds are particularly useful as therapeutic agents, and especially as antiviral agents.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7217815 2-beta -modified-6-substituted adenosine analogs and their use as antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us